Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer

被引：0
作者：
Son, Ji [1 ]
Cain, Katherine E. [2 ]
Marten, Claire A. [2 ]
Dwyer, Kaitlin W. [1 ]
Sims, Travis T. [1 ]
Taylor, Jolyn S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pharm Clin Programs, Houston, TX USA
来源：
GYNECOLOGIC ONCOLOGY REPORTS | 2024年 / 56卷
关键词：
SQUAMOUS-CELL-CARCINOMA; PREVIOUSLY TREATED RECURRENT; PHASE-II; TISSUE FACTOR; PERSISTENT; TRIAL;
D O I：
10.1016/j.gore.2024.101525
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phase II Study on Weekly Bolus Topotecan in Advanced or Recurrent Cervical Cancer
    Lorusso, D.
    Mainenti, S.
    Pietragalla, A.
    Fusco, E.
    Malaguti, P.
    Masciullo, V.
    Scambia, G.
    ONCOLOGY, 2011, 80 (5-6) : 390 - 394
  • [42] Synergistic therapeutic effect of low-dose bevacizumab with cisplatin-based chemotherapy for advanced or recurrent cervical cancer
    Liu, Chia-Hao
    Kung, Yen-Hsuan
    Lin, Jeff Chien-Fu
    Chuang, Chi-Mu
    Wu, Hua-Hsi
    Jiang, Ling-Yu
    Shih, Ying-Chu
    Wang, Peng-Hui
    Chen, Yi-Jen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (12) : 1139 - 1144
  • [43] Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer
    Eskander, Ramez N.
    Tewari, Krishnansu S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (04) : 314 - 321
  • [44] Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature
    D'Oria, Ottavia
    Bogani, Giorgio
    Cuccu, Ilaria
    D'Auge, Tullio Golia
    Di Donato, Violante
    Caserta, Donatella
    Giannini, Andrea
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (01) : 55 - 65
  • [45] Management of advanced or recurrent cervical cancer: chemotherapy and beyond
    Elit, Laurie M.
    Hirte, Hal
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (03) : 319 - 332
  • [46] Chemotherapy and molecular targeting therapy for recurrent cervical cancer
    Tsuda, Naotake
    Watari, Hidemichi
    Ushijima, Kimio
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (02) : 241 - 253
  • [47] Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey
    Richardson, Michael T.
    Attwood, Kristopher
    Smith, Gabriella
    Liang, Su-Ying
    LaVigne Mager, Katherine
    Tewari, Krishnansu S.
    Coleman, Robert L.
    Kapp, Daniel S.
    Chan, John K.
    Monk, Bradley J.
    CANCER CONTROL, 2023, 30
  • [48] Pattern of disease and response to pembrolizumab in recurrent cervical cancer
    Miller, Kathryn M.
    Filippova, Olga T.
    Hayes, Sara A.
    Abu-Rustum, Nadeem R.
    Aghajanian, Carol
    Broach, Vance
    Ellenson, Lora H.
    Selenica, Pier
    Jewell, Elizabeth L.
    Kyi, Chrisann
    Lakhman, Yuliya
    Mueller, Jennifer J.
    O'Cearbhaill, Roisin E.
    Park, Kay J.
    Sonoda, Yukio
    Zamarin, Dmitriy
    Weigelt, Britta
    Leitao, Mario M.
    Friedman, Claire F.
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [49] An Oral Small Molecule VEGFR2 Inhibitor, Apatinib, in Patients with Recurrent or Refractory Cervical Cancer: A Real World Study
    Li, Ning
    Wang, Ziyi
    Yuan, Guangwen
    Sun, Yangchun
    Zhang, Rong
    Li, Xiaoguang
    Li, Nan
    Wang, Jing
    Wu, Lingying
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [50] Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis
    Alholm, Zachary
    Monk, Bradley J.
    Ting, Jie
    Pulgar, Sonia
    Boyd, Marley
    Sudharshan, Lavanya
    Bains, Savreet
    Nicacio, Leonardo
    Coleman, Robert L.
    GYNECOLOGIC ONCOLOGY, 2021, 161 (02) : 422 - 428
12345